1. Stocks
  2. Arrowhead Pharmaceuticals Inc.
  3. Swot
swot-logo

Arrowhead Pharmaceuticals Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Arrowhead Pharmaceuticals Inc. has 5 Strengths, 28 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

PEG lower than Industry PEG

Relative Outperformance versus Industry over 10 Years

Relative Outperformance versus Industry over 1 Week

Stock with Low PE (PE < = 10)

Negative Breakdown Second Support (LTP < S2)

Stocks with Quarter Change % less than Industry

Companies with High Debt

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Highest fall from 52 Week High

Top Losers

Near 52 Week Low

Negative Breakdown First Support (LTP < S1)

Negative Breakdown Second Support (LTP < S2)

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Companies Increasing Debt as per Annual Report

RSI indicating price weakness

Near 52 Week Low

Top Losers

Zombies: Companies whose interest payments are higher than revenues

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ